Jinxin Fertility Group IPO Preview: Baby Boom or Bust?
Jinxin Fertility Co Ltd (1659778D CH) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...
1.1k Views
Frontage Holdings (ę¹č¾¾ę§č”) Post-IPO Trading Update: Strong Demand and Volume but Fairly Valued
Frontage Holdings IPO attracted strong demand and was priced at the high end of the IPO pricing. In our previous insight, we have discussed that...
704 Views
Frontage Holdings IPO: Bull/āāBear Case DCF Scenarios
Frontage Holdings (1521 HK) is a global contract research organisation (CRO) which is backed byĀ Hangzhou Tigermed Consulting (300347 CH)....
769 Views
Frontage Holdings IPO: Risk-Reward Is Favourable at the Low-End of Price Range
Frontage Holdings (1521 HK)Ā has launched its Hong Kong IPO at a price range of HK$2.55-3.20 per share to raise HK$1.27-1.60 billion ($160-200...
864 Views
Frontage Holdings (ę¹č¾¾ę§č”) IPO:Ā Reasonable Valuation & Quality Cornerstones
Frontage Holdings,Ā a pre-clinical CRO arm of A-share listed Hangzhou Tigermed Consulting (300347 CH),Ā started book building today to raise up to...
931 Views